AMA Opposes Bills Pushing Coprescription of Opioids and Naloxone

North and South Carolina lawmakers are considering bills that would require clinicians to coprescribe naloxone for patients who are prescribed opioids. However, the American Medical Association (AMA) and both states’ medical associations oppose the legislation. Prescribers who fail to coprescribe these medications could be subject to discipline “by the appropriate licensing board,” notes the proposed South Carolina Senate Bill 571. […]

Read more

Does Naltrexone Have a Role in Harm-Reduction Strategies for Homeless People With Alcohol Misuse?

NEW YORK (Reuters Health) – Adding extended-release naltrexone to a behavioral harm-reduction strategy did not appear to improve alcohol-related outcomes and physical health-related quality of life in homeless people who drink too much, new research indicates. But the behavioral harm-reduction strategy, with or without naltrexone, did produce benefits compared with services as usual, researchers report in The Lancet Psychiatry. People […]

Read more

Addiction treatment centers using electronic health records less and may hinder care

Despite their existence for decades, electronic health records—digitized patient information and medical histories available instantly and securely to authorized users—are not commonly used by many addiction and substance use disorder treatment facilities in the United States. Now, a recent study by Johns Hopkins Medicine researchers suggests why this is happening. It also describes how not using this technology may hinder […]

Read more

Lonely adolescents are susceptible to internet addiction: Increasing numbers at risk in the coronavirus situation

Loneliness is a risk factor associated with adolescents being drawn into compulsive internet use. The risk of compulsive use has grown in the coronavirus pandemic: loneliness has become increasingly prevalent among adolescents, who spend longer and longer periods of time online. A study investigating detrimental internet use by adolescents involved a total of 1,750 Finnish study subjects, who were studied […]

Read more

Study explains why antipsychotic medications lead to weight gain, promote metabolic syndrome

Why do patients who receive antipsychotic medications to manage schizophrenia and bipolar disorder quickly gain weight and develop prediabetes and hyperinsulemia? The question remained a mystery for decades, but in a paper published today in Translational Psychiatry, researchers from the University of Pittsburgh School of Medicine finally cracked the enigma. Antipsychotic drugs, scientists showed, not only block dopamine signaling in […]

Read more

Oxycodone Mylan

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. OXYCODONE MYLAN oxycodone hydrochloride Consumer Medicine Information WARNING Limitations of use OXYCODONE MYLAN should only be used when your doctor decides that other treatment options are not able to effectively manage your pain or you cannot tolerate them. Hazardous and harmful use OXYCODONE MYLAN poses risks of […]

Read more

Tramadol Mylan SR (formerly Tramedo SR)

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. TRAMADOL MYLAN SR Tramadol hydrochloride modified release tablets CONSUMER MEDICINE INFORMATION What is in this leaflet This leaflet answers some common questions about Tramadol Mylan SR. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. […]

Read more
1 2 3 5